- Selective laser trabeculoplasty (SLT) reduced medication use and provided additional intraocular pressure control for open-angle glaucoma and ocular hypertension.
- SLT may offer a cost-effective approach for glaucoma treatment.
- The study reported a significant reduction in medication burden for participants switching to SLT after 3 years of eye drop use.
- In stable eyes, SLT showed potential for eye drop–free intraocular pressure control for at least 3 years.
- SLT may not fully prevent the need for definitive surgical pressure lowering in advanced glaucoma cases.
LiGHT Trial Data Shows Efficacy in Decreasing Medication Burden with SLT
Conexiant
March 12, 2025
